ATXN2 and amyotrophic lateral sclerosis: Amplification of intermediate-length ATXN2 CAG repeats is closely associated with ALS, and such expansions likely enhancing the stability or impeding the degradation of ATXN2, resulting in an elevated effective concentration of the protein [6].